<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16637">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02890303</url>
  </required_header>
  <id_info>
    <org_study_id>MYN-002</org_study_id>
    <nct_id>NCT02890303</nct_id>
  </id_info>
  <brief_title>A Prospective Multi-Center Study of Anterior Lens Capsulotomy Using the Mynosys Zepto System</brief_title>
  <official_title>A Prospective Multi-Center Study of Anterior Lens Capsulotomy Using the Mynosys Zepto System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mynosys Cellular Devices, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mynosys Cellular Devices, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate outcome in subjects who have elected to have Zepto capsulotomies
      during cataract surgery with phacoemulsification.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate outcome in subjects who have elected to have Zepto capsulotomies
      during cataract surgery with phacoemulsification to evaluate safety and effectiveness. The
      primary effectiveness endpoint is a complete capsulotomy in at least 95 percent of the
      cases. The primary safety endpoint is posterior capsular rupture and virtuous loss in 4
      percent or less of the subjects. Other parameters to be captured during the study include
      anterior capsule tears, corneal touch, capsulotomy diameter, contraption of the Zepto
      capsulotomy, size of the corneal incision pre and post Zepto, interocular lens contraption
      and evaluation of zonular stability and the incidence and severity of adverse events. The
      criteria for patient success will be accessed based on the successful completion of a 360
      degree capsulotomy without tissue bridges and no posterior capsule rupture and vitreous
      loss. The criteria for study success will be accessed based on a greater than or equal to 95
      percent of the cases having a complete 360 degree capsulotomy without tissue bridges and
      less than 4 percent of subjects with posterior capsule rupture and vitreous loss.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete Capsulotomy</measure>
    <time_frame>Follow-up up to 3 months</time_frame>
    <description>A successful complete Zepto capsulotomy is defined in this protocol to be one that results in a complete 360 degree capsulotomy without any residual tissue bridges visible to the surgeon. If there are such tissue bridges, the surgeon completes the capsulotomy manually.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Zepto Capsulotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This study will evaluate outcome in subjects who have elected to have Zepto capsulotomies during cataract surgery. Effectiveness Rate - An effectiveness rate of 95% complete capsulotomies provides reasonable assurance that the Zepto system is effective. Primary Safety Endpoint - Posterior Capsular Rupture &amp; Vitreous Loss (4% or less)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zepto System</intervention_name>
    <description>Anterior Capsulotomy using the Zepto System.</description>
    <arm_group_label>Zepto Capsulotomy</arm_group_label>
    <other_name>Zepto</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects must be age 22 or older,

          2. Subjects consenting to undergoing phacoemulsification and IOL implant surgery for the
             treatment of symptomatic age related lens cataract, and then electing to undergo
             ZeptoTM capsulotomy,

          3. Subjects must be willing and able to return for scheduled treatment and follow-up
             examinations for 3 months.

        Exclusion Criteria:

          1. Disease or pathology in the treatment eye that will compromise visual performance or
             refractive outcome (e.g. previous refractive surgery),

          2. Zonular abnormality,

          3. Posterior polar cataract,

          4. Fellow eye with acuity less than 20/200,

          5. Any prior ocular surgery of the study eye,

          6. Pupillary dilation during the pre-operative exam of less than 7 mm in diameter,

          7. Proliferative diabetic retinopathy,

          8. Disorders of the ocular muscles, such as nystagmus or strabismus,

          9. Chronic uveitis,

         10. Abnormal corneal endothelium,

         11. Subjects on medications with, in the opinion of the surgeon, significant ocular side
             effects,

         12. Pregnant or nursing (lactating) women,

         13. Implanted ocular device or drug in the study eye,

         14. Any other condition, which in the judgment of the investigator would prevent the
             subject from completing the study (e.g. documented diagnosis or treatment for
             symptoms associated with dementia, mental illness),

         15. Current participation in another drug or device clinical study, or participation in
             such a clinical study within the six months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Daniel S Marinsik, B.S.</last_name>
    <phone>5108576296</phone>
    <email>dmarinsik@mynosys.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>John Hendrick, B.A.</last_name>
    <phone>5103961531</phone>
    <email>jhendrick@mynosys.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Chang DF, Mamalis N, Werner L. Precision Pulse Capsulotomy: Preclinical Safety and Performance of a New Capsulotomy Technology. Ophthalmology. 2016 Feb;123(2):255-64. doi: 10.1016/j.ophtha.2015.10.008. Epub 2015 Nov 12.</citation>
    <PMID>26578447</PMID>
  </reference>
  <reference>
    <citation>Carifi G, Miller MH, Pitsas C, Zygoura V, Deshmukh RR, Kopsachilis N, Maurino V. Complications and outcomes of phacoemulsification cataract surgery complicated by anterior capsule tear. Am J Ophthalmol. 2015 Mar;159(3):463-9. doi: 10.1016/j.ajo.2014.11.027. Epub 2014 Nov 26.</citation>
    <PMID>25461300</PMID>
  </reference>
  <reference>
    <citation>Agrawal V, Upadhyay J; Indian Cataract Risk Stratification Study group.. Validation of scoring system for preoperative stratification of intra-operative risks of complications during cataract surgery: Indian multi-centric study. Indian J Ophthalmol. 2009 May-Jun;57(3):213-5. doi: 10.4103/0301-4738.49396.</citation>
    <PMID>19384016</PMID>
  </reference>
  <reference>
    <citation>Ang GS, Whyte IF. Effect and outcomes of posterior capsule rupture in a district general hospital setting. J Cataract Refract Surg. 2006 Apr;32(4):623-7.</citation>
    <PMID>16698484</PMID>
  </reference>
  <reference>
    <citation>Chan FM, Mathur R, Ku JJ, Chen C, Chan SP, Yong VS, Au Eong KG. Short-term outcomes in eyes with posterior capsule rupture during cataract surgery. J Cataract Refract Surg. 2003 Mar;29(3):537-41.</citation>
    <PMID>12663021</PMID>
  </reference>
  <reference>
    <citation>Desai P, Minassian DC, Reidy A. National cataract surgery survey 1997-8: a report of the results of the clinical outcomes. Br J Ophthalmol. 1999 Dec;83(12):1336-40.</citation>
    <PMID>10574810</PMID>
  </reference>
  <reference>
    <citation>Greenberg PB, Tseng VL, Wu WC, Liu J, Jiang L, Chen CK, Scott IU, Friedmann PD. Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans. Ophthalmology. 2011 Mar;118(3):507-14. doi: 10.1016/j.ophtha.2010.07.023. Epub 2010 Oct 29.</citation>
    <PMID>21035868</PMID>
  </reference>
  <reference>
    <citation>Hyams M, Mathalone N, Herskovitz M, Hod Y, Israeli D, Geyer O. Intraoperative complications of phacoemulsification in eyes with and without pseudoexfoliation. J Cataract Refract Surg. 2005 May;31(5):1002-5.</citation>
    <PMID>15975469</PMID>
  </reference>
  <reference>
    <citation>Ionides A, Minassian D, Tuft S. Visual outcome following posterior capsule rupture during cataract surgery. Br J Ophthalmol. 2001 Feb;85(2):222-4.</citation>
    <PMID>11159491</PMID>
  </reference>
  <reference>
    <citation>Lundstr√∂m M, Barry P, Leite E, Seward H, Stenevi U. 1998 European Cataract Outcome Study: report from the European Cataract Outcome Study Group. J Cataract Refract Surg. 2001 Aug;27(8):1176-84.</citation>
    <PMID>11524187</PMID>
  </reference>
  <reference>
    <citation>Martin KR, Burton RL. The phacoemulsification learning curve: per-operative complications in the first 3000 cases of an experienced surgeon. Eye (Lond). 2000 Apr;14 ( Pt 2):190-5.</citation>
    <PMID>10845015</PMID>
  </reference>
  <reference>
    <citation>Zaidi FH, Corbett MC, Burton BJ, Bloom PA. Raising the benchmark for the 21st century--the 1000 cataract operations audit and survey: outcomes, consultant-supervised training and sourcing NHS choice. Br J Ophthalmol. 2007 Jun;91(6):731-6. Epub 2006 Oct 18.</citation>
    <PMID>17050577</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 31, 2016</lastchanged_date>
  <firstreceived_date>August 31, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
